Target intelligence / Profile preview

GCNT2 pseudogene 1 (GCNT2P1)

Target
GCNT2P1
Molecular classification
Other, Pseudogene
01

Overview

GCNT2 pseudogene 1 (GCNT2P1) is a genomically encoded pseudogene closely related to the functional GCNT2 gene, which encodes glucosaminyl (N-acetyl) transferase 2, the I-branching enzyme involved in blood group I antigen biosynthesis. GCNT2P1 is cataloged as a pseudogene and, based on current genomic and experimental evidence, does not produce a functional protein, nor is it involved in cellular biological processes, disease, or drug interactions. No experimentally validated function or protein product is known for GCNT2P1; functional and disease associations belong exclusively to the active GCNT2 gene. It is not considered a therapeutic target (not a receptor, enzyme, transporter, or regulator). None of the listed aliases refer to a functional or disease-relevant protein in the context of GCNT2P1; roles and mechanisms belong to the active GCNT2 gene, not the pseudogene. Essentially all information about disease, mechanism, drug interaction, and biomarker relevance applies to GCNT2, not GCNT2P1. In summary, GCNT2P1 is a well-characterized human pseudogene with no known protein product, biological function, or disease association. Information about target biology and drug action applies only to the functional GCNT2 gene, not the pseudogene.

Other names
bA421M1.3GCNT2PGCNT6beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 6glucosaminyl (N-acetyl) transferase 2I-branching enzyme (I blood group) pseudogeneglucosaminyl (N-acetyl) transferase 6GCNT2P1

Beyond the preview

Go deeper on GCNT2 pseudogene 1 (GCNT2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GCNT2 pseudogene 1 (GCNT2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call